Tollovir (NLC-V-01) / Todos Medical  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Tollovir (NLC-V-01) / Todos Medical
NCT05226767: Effect of Daily Oral Administration of Food Supplement NLC-V in Patients Diagnosed With COVID-19

Completed
2
31
RoW
NLC-V
Todos Medical, Ltd.
COVID-19
11/21
01/22

Download Options